[1]
“COMPARISON OF INHALED COLISTIN VERSUS INTRAVENOUS COLISTIN FOR GRAM-NEGATIVE HOSPITAL-ACQUIRED PNEUMONIA: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL”, JMHSR, vol. 2, no. 2, Jun. 2025, doi: 10.62019/qr5ccp16.